Unknown

Dataset Information

0

An Energetically Favorable Ligand Entrance Gate of a Multidrug Transporter Revealed by Partial Nudged Elastic Band Simulations.


ABSTRACT: P-glycoprotein (P-gp) is a multidrug transporter, which harnesses the chemical energy of ATP to power the efflux of diverse chemotherapeutics out of cells and thus contributes to the development of multidrug resistance (MDR) in cancer. It has been proved that the ligand-binding pocket of P-gp is located at the transmembrane domains (TMDs). However, the access of ligands into the binding pocket remains to be elucidated, which definitely hinder the development of P-gp inhibitors. Herein, the access pathways of a well-known substrate rhodamine-123 and a cyclopeptide inhibitor QZ-Leu were characterized by time-independent partial nudged elastic band (PNEB) simulations. The decreasing free energies along the PNEB-optimized access pathway indicated that TM4/6 cleft may be an energetically favorable entrance gate for ligand entry into the binding pocket of P-gp. The results can be reconciled with a range of experimental studies, further corroborating the reliability of the gate revealed by computational simulations. Our atomic level description of the ligand access pathway provides valuable insights into the gating mechanism for drug uptake and transport by P-gp and other multidrug transporters.

SUBMITTER: Xing J 

PROVIDER: S-EPMC6406077 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

An Energetically Favorable Ligand Entrance Gate of a Multidrug Transporter Revealed by Partial Nudged Elastic Band Simulations.

Xing Juan J   Mei Hu H   Huang ShuHeng S   Zhang Duo D   Pan XianChao X  

Computational and structural biotechnology journal 20190222


P-glycoprotein (P-gp) is a multidrug transporter, which harnesses the chemical energy of ATP to power the efflux of diverse chemotherapeutics out of cells and thus contributes to the development of multidrug resistance (MDR) in cancer. It has been proved that the ligand-binding pocket of P-gp is located at the transmembrane domains (TMDs). However, the access of ligands into the binding pocket remains to be elucidated, which definitely hinder the development of P-gp inhibitors. Herein, the acces  ...[more]

Similar Datasets

| S-EPMC2818052 | biostudies-literature
| S-EPMC3349012 | biostudies-literature
| S-EPMC3485559 | biostudies-literature
| S-EPMC7314423 | biostudies-literature
| S-EPMC5614849 | biostudies-literature
| S-EPMC4993762 | biostudies-literature
| S-EPMC3065909 | biostudies-literature
| S-EPMC4245991 | biostudies-literature
| S-EPMC9126977 | biostudies-literature
| S-EPMC5785007 | biostudies-literature